Professor Dietmar Hutmacher
Professor Hutmacher is the Chair in Regenerative Medicine and leads a dynamic multidisciplinary research group. His research interests include biomaterials, biofabrication, biomechanics, medical devices, cancer and tissue engineering.
Research in this area is conducted by the Orthopaedics, trauma and emergency care program, a multi-disciplinary group internationally recognised for the application of biomedical engineering techniques to provide new technologies, materials, procedures and medical devices.
The research incorporates expertise in the broad range of areas focused on issues encountered in musculoskeletal clinical practice, which include:
- animal models
- cartilage biomechanics
- cell biology
- cell biomechanics
- clinical research
- emergency medicine
- quantitative imaging
- mathematical modelling
- mechanical testing
- regenerative medicine
- spinal deformity and spinal disease
- surgical implants
- tissue engineering
- tissue mechanics.
Institute of Health and Biomedical Innovation (IHBI)
The Institute of Health and Biomedical Innovation (IHBI) has world-class facilities for cell culture, biofabrication, mechanical testing, molecular biology, imaging, and histology.
Medical Engineering Research Facility (MERF)
Located at The Prince Charles Hospital, the Medical Engineering Research Facility (MERF) is a world-class training, education and research facility with the advanced surgical skills laboratory (ASSL) and biological research facility (BRF). MERF has small and large animal facilities to allow for sophisticated in vivo models of new devices and techniques.
Central Analytical Research Facility (CARF)
Part of the Institute for Future Enviroments, the Central Analytical Research Facility (CARF) has state-of-the-art infrastructure for material analysis (e.g. electron microscopes, atomic force microscopes) and systems biology (mass spectrometers, next generation sequencers).
Science and Engineering Faculty
The Science and Engineering Faculty has a large rapid prototyping facility, machine shop, six axis spine testing robot, a nuclear magnetic resonance (NMR) facility, and a suite of mechanical testing instruments.
Translational Research Institute (TRI)
The Translational Research Institute (TRI) is a unique, Australian-first initiative of 'bench to bedside' medical research. TRI combines clinical and translational research to advance progress from laboratory discovery to application in the community.
Evidence of research quality
ERA (Excellence in Research for Australia) 2015 score:
- 4 (above world standard) -
- Biomedical Engineering (FOR 0903).
ERA (Excellence in Research for Australia) evaluates the quality of research undertaken in Australian universities against national and international benchmarks.
Developing new researchers
- Higher degree research students
- 2013 total
- $4.31 million
- Australian Research Council (ARC) Future Fellowship (Professor Dietmar Hutmacher, Associate Professor Travis Klein)
- Australian Research Council (ARC) Linkage Grants (Associate Professor Mia Woodruff)
- National Health and Medical Research Council (NHMRC) grant (Professor Dietmar Hutmacher, Professor Michael Schuetz)
- Professor Dietmar Hutmacher
- Professor Michael Schuetz
- Emeritus Professor Mark Pearcy
- Professor Yin Xiao
- Professor Ross Crawford
- Professor Christian Langton
- Professor Gerard Fitzgerald
- Professor Gregory Kyle
- Professor Pamela Rowntree
- Professor Vivienne Tippett
- Adjunct Professor Kunle Oloyede
- Associate Professor Travis Klein
- Associate Professor Mia Woodruff
- Associate Professor Scott Wearing
- Associate Professor Clayton Adam
- Associate Professor Laura Gregory
- Associate Professor Prashant Sonar
- Associate Professor Xiang-Yu Hou
- Dr Daniela Loessner
- Dr Fatemeh Chehrehasa
- Dr Marie-Luise Wille
The Australia-China Centre for Tissue Engineering and Regenerative Medicine brings together new and longstanding collaborations between QUT and seven prestigious institutes and universities in China. It aids in creating a highly visible hub for research collaboration and the attraction of competitive research funding in this field.
The FP7 (European Commission 7th Framework Programme for Research and Technological Development) HydroZONES project represents an interdisciplinary consortium (15 European partners and QUT) that adopts a strategy to regenerate articular cartilage based on biofunctional hydrogel-based implants that mimic the tissues zonal structure and function.
Significant corporate partnerships
Strong links have been established with medical researchers and clinical specialists at hospitals, including the Prince Charles Hospital, Princess Alexandra Hospital and Mater Children's Hospital, as well as with industry end-users, ensuring that the outcomes of our research and development address current and future clinical needs.
We attract funding from international and Australian industry and foundations, including:
- Stryker Australia Pty Ltd
- Synthes Australia Pty Ltd
- DePuy Australia Pty Ltd
- Medtronic Sofamor Danek and Medtronic SNT
- Zimmer Pty Ltd
- Smith & Nephew
- AO Research Fund
- Prince Charles Hospital Foundation
- Princess Alexandra Research Foundation
- Wesley Research Institute
- Queensland Orthopaedic Research Trust
IHBI research enquiries
Contact us to find out about research and discovery at the Institute of Health and Biomedical Innovation (IHBI).
- Phone: 3138 6000
- Email: email@example.com